Company Information

CIPLA LTD.

NSE : CIPLABSE : 500087ISIN CODE : INE059A01026Industry : Pharmaceuticals & DrugsHouse : Cipla
BSE1494.6528.45 (+1.94 %)
PREV CLOSE ( ) 1466.20
OPEN PRICE ( ) 1469.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 60392
TODAY'S LOW / HIGH ( )1462.40 1513.10
52 WK LOW / HIGH ( )885.35 1519
NSE1496.9533.6 (+2.3 %)
PREV CLOSE( ) 1463.35
OPEN PRICE ( ) 1472.00
BID PRICE (QTY) 1496.95 (16)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2110407
TODAY'S LOW / HIGH( ) 1461.15 1514.20
52 WK LOW / HIGH ( )885.35 1519
ChairmanY K Hamied
Managing DirectorUmang Vohra
Company SecretaryRajendra Chopra
Vice ChairmanMK Hamied
Executive Vice ChairmanSamina Hamied
Non Executive Independent DirectorAdil Zainulbhai
Ashok Sinha
Punita Lal
PR Ramesh
Robert Stewart
Mandar Purushottam Vaidya
Non Independent & Non Executive DirectorS Radhakrishnan
Incorporation Year : 17-08 1935

Registered Office :

Address : Cipla House, Peninsula Business Park,Ganpatrao Kadam Marg,Lower Parel Mumbai,
Maharashtra-400013 .

Phone : 022-24826000

Email :  contactus@cipla.com 

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE,Luxembourg, MCX

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.